Development of Stimuli-Responsive Nanoparticles for Targeted Delivery of Encorafenib in BRAF-Mutant Cancer Therapy. (2026). International Journal of Research Development and Technology, 4(1), 85-109. https://doi.org/10.62218/ijrdt.v4i1.170